{Reference Type}: Journal Article
{Title}: Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment.
{Author}: Ueshima K;Komemushi A;Aramaki T;Iwamoto H;Obi S;Sato Y;Tanaka T;Matsueda K;Moriguchi M;Saito H;Sone M;Yamagami T;Inaba Y;Kudo M;Arai Y;
{Journal}: Liver Cancer
{Volume}: 11
{Issue}: 5
{Year}: Sep 2022
{Factor}: 12.43
{DOI}: 10.1159/000524893
{Abstract}: Hepatocellular carcinoma is one of the leading causes of cancer-related death both in Japan and globally. In the advanced stage, hepatic arterial infusion chemotherapy (HAIC) is one of the most commonly used treatment options for liver cancer in Japan, and implantation of a catheter system (called a port system) in the body is a treatment method that has evolved mainly in Japan. The Guideline Committee of the Japanese Society of Interventional Radiology and the Japanese Society of Implantable Port Assisted Treatment jointly published clinical practice guidelines for HAIC with a port system to ensure its appropriate and safe performance in Japanese in 2018. We have written an updated English version of the guidelines with the aim of making this treatment widely known to experts globally. In this article, the evidence, method, indication, treatment regimen, and maintenance of the system are summarized.